erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .
�we are glad that, at last, the commission is taking serious steps to fight air pollution before the court of justice,� clientearth lawyer ugo taddei said in a press release. .